Abstract
Background and aims: Tools to detect type 1 diabetes (T1D) individuals at overt cardiovascular disease (CVD) risk are scarce. We aimed to assess the usefulness of the score ‘Steno Type 1 Risk Engine’ (Steno‐Risk) to identify T1D patients with advanced carotid atherosclerosis.Material and methods: T1D patients without CVD with at least one of the following were included: ≥40 years, diabetic nephropathy, or diabetes duration ≥10 years with ≥1 CVD risk factor. Intima‐media thickness (IMT) and plaque presence (IMT ≥1.5 mm) were assessed by standardized B‐mode ultrasonography. Steno‐Risk was used to estimate 10‐year risk (P < .001 for all). Preclinical atherosclerosis (IMT and plaque) increased in parallel with Steno‐Risk (P < .001). In logistic regression analysis, both age ≥40 years and Steno‐Risk ≥20% were associated with the presence of plaque (OR 4.22 [1.57‐11.36] and 3.79 [1.61‐6.80]; respectively), but only high Steno‐Risk remained independently associated with ≥2 plaques (OR 3.31 [1.61‐6.80]).Conclusion: Steno‐Risk is independently associated with preclinical atherosclerosis. Further studies are needed to ascertain its usefulness in this high‐risk population.
Funding Information
  • Associació Catalana de Diabetis (“Ajut per a la recerca en diabetis modalitat clínica 2018”)
  • Hospital Clínic de Barcelona (“Premi Fi de Residencia 2018-2019”)

This publication has 40 references indexed in Scilit: